Delayed-release dimethyl fumarate demonstrated no evidence of difference in clinical outcomes vs fingolimod in patients with RRMS: a propensity-matched comparative effectiveness analysis of the German NeuroTransData registry

Author(s):  
Stefan Braune
2015 ◽  
Vol 18 (7) ◽  
pp. A495 ◽  
Author(s):  
S Torvinen ◽  
C Rémuzat ◽  
O Mzoughi ◽  
A Plich ◽  
M Toumi

Sign in / Sign up

Export Citation Format

Share Document